NGM Biopharmaceuticals
As of the edition of 20 October 2026, NGM Biopharmaceuticals runs 8 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Went quiet | 2 |
| Stopped | 2 |
| Status not established | 3 |
| Total | 8 |
Where its trials are
- Digestive system: 13 trials led
- Hormones: 6 trials led
- Cancer: 5 trials led